| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| B3gnt3 | Cd274 | ENSRNOP00000025362 | ENSRNOP00000029992 | Hexosyltransferase. | Similar to PD-1-ligand (Predicted). | 0.777 |
| Cd274 | B3gnt3 | ENSRNOP00000029992 | ENSRNOP00000025362 | Similar to PD-1-ligand (Predicted). | Hexosyltransferase. | 0.777 |
| Cd274 | Cd80 | ENSRNOP00000029992 | ENSRNOP00000002089 | Similar to PD-1-ligand (Predicted). | CD80 antigen, isoform CRA_a. | 0.993 |
| Cd274 | Ctla4 | ENSRNOP00000029992 | ENSRNOP00000073071 | Similar to PD-1-ligand (Predicted). | Cytotoxic T-lymphocyte-associated protein 4, isoform CRA_a. | 0.851 |
| Cd274 | Cul3 | ENSRNOP00000029992 | ENSRNOP00000021528 | Similar to PD-1-ligand (Predicted). | Cullin-3; Core component of multiple cullin-RING-based BCR (BTB-CUL3- RBX1) E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. BCR complexes and ARIH1 collaborate in tandem to mediate ubiquitination of target proteins (By similarity). As a scaffold protein may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin- protein ligase activity of the complex is dependent on the neddylation of the cullin subunit and is inhibited by the association of the [...] | 0.778 |
| Cd274 | Gsk3b | ENSRNOP00000029992 | ENSRNOP00000075708 | Similar to PD-1-ligand (Predicted). | Glycogen synthase kinase-3 beta; Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glyc [...] | 0.838 |
| Cd274 | Mib2 | ENSRNOP00000029992 | ENSRNOP00000023696 | Similar to PD-1-ligand (Predicted). | E3 ubiquitin-protein ligase MIB2; E3 ubiquitin-protein ligase that mediates ubiquitination of Delta receptors, which act as ligands of Notch proteins. Positively regulates the Delta-mediated Notch signaling by ubiquitinating the intracellular domain of Delta, leading to endocytosis of Delta receptors. | 0.793 |
| Cd274 | Pdcd1 | ENSRNOP00000029992 | ENSRNOP00000067189 | Similar to PD-1-ligand (Predicted). | Programmed cell death 1. | 0.991 |
| Cd274 | Pdcd1-2 | ENSRNOP00000029992 | ENSRNOP00000025743 | Similar to PD-1-ligand (Predicted). | Programmed cell death 1 (Predicted). | 0.997 |
| Cd274 | Pdcd1lg2 | ENSRNOP00000029992 | ENSRNOP00000021615 | Similar to PD-1-ligand (Predicted). | Programmed cell death 1 ligand 2. | 0.953 |
| Cd274 | Usp7 | ENSRNOP00000029992 | ENSRNOP00000041134 | Similar to PD-1-ligand (Predicted). | Ubiquitin carboxyl-terminal hydrolase 7; Hydrolase that deubiquitinates target proteins such as FOXO4, p53/TP53, MDM2, ERCC6, DNMT1, UHRF1, PTEN, KMT2E/MLL5 and DAXX. Together with DAXX, prevents MDM2 self-ubiquitination and enhances the E3 ligase activity of MDM2 towards p53/TP53, thereby promoting p53/TP53 ubiquitination and proteasomal degradation (By similarity). Deubiquitinates p53/TP53, preventing degradation of p53/TP53, and enhances p53/TP53-dependent transcription regulation, cell growth repression and apoptosis (By similarity). Deubiquitinates p53/TP53 and MDM2 and strongly s [...] | 0.775 |
| Cd80 | Cd274 | ENSRNOP00000002089 | ENSRNOP00000029992 | CD80 antigen, isoform CRA_a. | Similar to PD-1-ligand (Predicted). | 0.993 |
| Cd80 | Ctla4 | ENSRNOP00000002089 | ENSRNOP00000073071 | CD80 antigen, isoform CRA_a. | Cytotoxic T-lymphocyte-associated protein 4, isoform CRA_a. | 0.999 |
| Cd80 | Pdcd1 | ENSRNOP00000002089 | ENSRNOP00000067189 | CD80 antigen, isoform CRA_a. | Programmed cell death 1. | 0.698 |
| Cd80 | Pdcd1-2 | ENSRNOP00000002089 | ENSRNOP00000025743 | CD80 antigen, isoform CRA_a. | Programmed cell death 1 (Predicted). | 0.752 |
| Cd80 | Pdcd1lg2 | ENSRNOP00000002089 | ENSRNOP00000021615 | CD80 antigen, isoform CRA_a. | Programmed cell death 1 ligand 2. | 0.955 |
| Ctla4 | Cd274 | ENSRNOP00000073071 | ENSRNOP00000029992 | Cytotoxic T-lymphocyte-associated protein 4, isoform CRA_a. | Similar to PD-1-ligand (Predicted). | 0.851 |
| Ctla4 | Cd80 | ENSRNOP00000073071 | ENSRNOP00000002089 | Cytotoxic T-lymphocyte-associated protein 4, isoform CRA_a. | CD80 antigen, isoform CRA_a. | 0.999 |
| Ctla4 | Pdcd1 | ENSRNOP00000073071 | ENSRNOP00000067189 | Cytotoxic T-lymphocyte-associated protein 4, isoform CRA_a. | Programmed cell death 1. | 0.891 |
| Ctla4 | Pdcd1-2 | ENSRNOP00000073071 | ENSRNOP00000025743 | Cytotoxic T-lymphocyte-associated protein 4, isoform CRA_a. | Programmed cell death 1 (Predicted). | 0.929 |